Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2121-2126

  Thibout, D ^a   Kraemer, M ^a   Di Benedetto, M ^a   Saffar, L ^b   Gattegno, L ^b   Derbin, C ^a   Crepin M ^a  

^a SMBII   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Aggregation; bFGF; Breast cancer cell lines; Cell cycle; E cadherin; Sodium phenylacetate (NaPa)

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CADHERIN; PHENYLACETIC ACID; UVOMORULIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL AGGREGATION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; NEOPLASM PROTEINS; PHENYLACETATES; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 0032781505     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Samid D, Shack S, Sherman, LT: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52: 1988-1992, 1992.
2. Samid D, Shack S, Myers C: Selective growth arrest and maturation of prostate cancer cells in vitro by nontoxic, pharmacological concentrations of phenylacetate. J Clin Invest 91: 2288-2295, 1993.
3. Adam L, Crépin M, Savin C, Israel L: Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF-7ras cells in vitro and in nude mice. Cancer Res 55: 5156-5160, 1995.
4. Adam L, Crépin M, Israel L: Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras by Sodium phenylacetate and tamoxifen combination. Cancer Res 57: 1023-1029, 1995.
5. Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins A C, Weinberger MS, Headlee DJ, McCall NA, Samid D and Myers CE: A phase I pharmacokinetic study of intraveinous phenylacetate in patients with cancer. Cancer Res 54: 1690-1694, 1994.
6. Brusilow SW, Danney M, Waber LJ, Batshaw M, Burton B, Levitsky L, Roth K, McKeethren C, Ward J: Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310: 1630-1634, 1984.
7. Gibbs JB, Oliff A, Kohl NE: Farnesyltransferase inhibitors:ras research yields a potential cancer therapeutic. Cell 77: 175-178, 1994.
8. Takeichi M: Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59: 237-252, 1990.
9. Vleminck K, Vakaet L Jr, Marcel M, Fiers W, van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppresor role. Cell 66: 107-119, 1991.
10. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR: Epithelial (E) and placental (P) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250, 1993.
11. Marcel MM, Boterberg T, Noë V, Van Hoorde L, Vermeulen SJ, Bruyneel EA, Bracke ME: E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion. J Cell Phy 173: 271-274, 1997.
12. Bringuier PP, Umbas R, Schaafsma, Karthaus HFM, Debruyne FMJ and Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245, 1993.
13. Behrens J, Birchmeier W: Cell-cell adhesion in invasion and metastasis of carcinomas. Cancer Treat Res 71: 251-266, 1994.
14. Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasivness of human carcinomas cells. J Cell Biol 113: 173-185, 1991.
15. Mareel M, Bracke M and Von Roy F: Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin. Mol Biol Rep 19: 45-67, 1994.
16. Soule HD, Vasquez J, Long A: Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1409, 1973.
17. Horowitz KB, Mc Guire WL: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223-2224, 1978.
18. Kasid A, Lippman ME, Papageorge AG, Lowy DR, Gelman EP: Transfection of v-ras H DNA into MCF-7 human breast cancer cells bypasses dependance on estrogen for tumorigenicity. Science 228: 725-728, 1985.
19. Albini A, Graft J, Kitten GT: 17'Ω-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane. Proc Natl Acad Sci USA 83: 8182-8186, 1986.
20. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP and Byers S: Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: Relationship to morphology and invasive capacities. Cell Growth & Diff 2: 365-372, 1991.
21. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuoyoshi N, Hirano S, Takeichi M, Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993.
22. Mareel MM, Behrens J, Birchmeier W, De Bruine GK, Vleminckx K, Hoogewus A, Fiers WC, van Roy FM: Down-regulation of E-cadherin expression in madin darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 47: 922-928, 1991.
23. Caulin C, Lopez-Barcons L, Gonzales-Garrigues M, Navarro P, Lozano E, Rodrigo I, Gamallo C, Cano A, Fabra A, Quintanilla M: Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Haras oncogene products., Mol Carcinog 15: 104-114, 1996.
24. Watabe M., Nagafuchi A, Tsukita S, Takeichi M: Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127: 247-256, 1994.
25. Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, Vleminckx K, Van Roy FM. and Mareel MM: Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 68: 282-289, 1993.
26. Bracke ME, Van Larebeke NA, Vyncke BM and Mareel MM: Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 hyman mammary carcinoma cells in vitro. Br J Cancer 63: 867-872, 1991.
27. Bracke ME, Vyncke BM, Van Larebeke NA, Bruyneel EA, De Pestel GH, De Coster WJ, Espeel MF and Mareel MM: The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic heart in vitro. Clin Exp Metastasis 7: 283-300, 1989.
28. Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM and Castronovo V: Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res 54: 46007-46009, 1994.